Biotech componentsBacteria

Products 21 to 30 of 53

Biopolymer I6001 by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/01 09:56 (6 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Biopolymer I6003rp by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/01 09:56 (6 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Biopolymer Mvera B5010 (Mirel) by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Biopolymer Mvera B5011 (Mirel) by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Biotech components: Bacteria
Business models: B2B
Country of production: Norway
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Venture Capital
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
DNA Based Memory Device by Wyss Institute + Harvard University
Biotech components: Bacteria
Business models: B2C
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 37,000,000 USD
Funding types: University + Government
Industry: Security
Market status: Under Development
Organization type(s): Private Company
Product categories: Threat detection
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Bacteria
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Government
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/08/20 15:56 (5 years ago)
Known funding amount: N/A
Funding types: Public Funding
Industry: Health
Market status: Under Development
Organization type(s): Government
Product categories: Medical Treatment
Production process: Open Release
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Bacteria
Business models: N/A
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/04/01 10:01 (6 years ago)
Date last modified: 2019/04/01 10:01 (6 years ago)
Known funding amount: N/A
Funding types: Government
Industry: Security
Market status: Under Development
Organization type(s): Government
Product categories: Threat detection
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Biotech components: Bacteria
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: N/A
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Resource Extraction
Production process: Open Release
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Ethanol from Gas by Lanza Tech
Biotech components: Bacteria
Business models: B2C
Country of production: USA
Country of distribution: USA + China
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 204,300,000 USD
Funding types: Venture Capital
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Platform